Why Was My Wegovy Prior Authorization Denied?

You received a prescription for Wegovy, brought it to the pharmacy, and expected the prescription to be filled. Instead, you were told that the medication requires prior authorization, or that your insurance company denied the request.

This guide explains the most common reasons Wegovy is denied and what you, your prescriber, and your pharmacy may be able to do next.

What Is Wegovy?

Wegovy contains semaglutide, a glucagon-like peptide-1 receptor agonist commonly called a GLP-1 medication.

As of 2026, FDA-approved Wegovy formulations include injections and tablets. Depending on the formulation and patient, Wegovy may be used for long-term weight reduction, cardiovascular risk reduction, or certain other approved indications. Wegovy injection is also approved for adolescents ages 12 and older with obesity and for qualifying adults with noncirrhotic metabolic dysfunction-associated steatohepatitis, or MASH.¹

FDA approval, however, does not guarantee that every health insurance plan will cover the medication for every approved use.

What Is Prior Authorization?

Prior authorization is a coverage-review process. Before the insurance plan agrees to pay for a medication, the prescriber may need to submit information showing that the patient meets the plan's requirements.

The insurance company may request information such as:

• The patient's diagnosis
• Height, weight, and body mass index
• Weight-related health conditions
• Previous weight-management treatments
• Participation in nutrition or lifestyle programs
• Medical reasons other medications cannot be used
• The requested dose and formulation
• Evidence that the patient is benefiting from continued treatment

The exact criteria can differ considerably between insurance plans, employers, diagnoses, and benefit designs.

1. Weight-Management Medications May Be Excluded From Your Plan

One of the most important questions is whether your insurance plan covers medications used for weight management at all.

Many employer-sponsored and commercial plans exclude weight-loss medications from the pharmacy benefit entirely, specifically to manage plan costs. When this happens, a patient may meet the FDA-approved indication and still be unable to obtain coverage under that plan.²

This is called a benefit exclusion.

A benefit exclusion is different from a clinical prior authorization denial. With a clinical denial, the medication may be covered when certain criteria are met. With a benefit exclusion, the entire medication category or indication may not be included in the plan, regardless of medical necessity.

Ask your insurance company:

“Is Wegovy excluded from my plan, or can it be covered if prior authorization requirements are met?”

That one question can save several laps around the insurance carousel.

2. The Prior Authorization Was Never Submitted

Sometimes the pharmacy tells a patient that prior authorization is required, but the request has not yet reached the insurance company.

The pharmacy generally sends an electronic notice or fax to the prescriber. The prescriber's office must then complete the required form or electronic questionnaire and send the information to the health plan.

Delays can occur when:

• The pharmacy has outdated prescriber information
• The prescriber did not receive the request
• The request was sent to the wrong office
• The office has not yet completed the form
• The plan requires a different form
• The request was submitted to the medical benefit instead of the pharmacy benefit, or vice versa

Ask the prescriber's office whether the prior authorization was received and the date it was submitted.

3. Required Documentation Was Missing

A request can be denied even when the patient appears to meet the requirements if the supporting information was not included.

Common missing information may include:

• The patient's current BMI
• Baseline weight before treatment
• A documented weight-related health condition
• Dates of previous medication trials
• Reasons prior medications were stopped
• Documentation of lifestyle modification
• The requested treatment indication
• Records supporting cardiovascular disease
• Evidence of response for a continuation request

Insurance reviewers generally make the decision using the information they receive. Information that exists in the medical record but was not submitted may not be considered.

A request denied for missing documentation may sometimes be corrected and resubmitted without requiring a lengthy formal appeal.

4. Your BMI Did Not Meet the Plan's Requirement

Insurance policies often use BMI as part of their coverage criteria for chronic weight management.

A plan may require documentation of obesity or overweight accompanied by at least one qualifying weight-related condition. Some policies may impose requirements that are more restrictive than the FDA-approved indication.

The plan may also require the BMI that was documented before the patient started Wegovy or another weight-management medication. A patient who has already lost weight should make sure the prescriber includes the appropriate baseline measurements when allowed by the policy.

Because requirements differ, do not assume that a friend, coworker, or family member with the same BMI will receive the same coverage decision.

5. A Weight-Related Health Condition Was Not Documented

When a patient does not meet a plan's obesity threshold, the plan may require a qualifying weight-related condition.

Examples that may be considered by some plans include:

• High blood pressure
• Abnormal cholesterol
• Obstructive sleep apnea
• Cardiovascular disease
• Prediabetes
• Type 2 diabetes
• Other conditions identified in the plan's written criteria

The diagnosis may need to appear in the submitted medical records rather than only being mentioned during an office visit.

The insurance plan's exact list controls the coverage decision. A medical condition that is clinically relevant may not necessarily appear on every plan's qualifying list.

6. The Plan Requires a Lifestyle or Weight-Management Program

Some plans require evidence that the patient has participated in a comprehensive weight-management program involving nutrition, physical activity, or behavioral modification.

The requirement may include:

• A minimum participation period
• Regular follow-up visits
• A reduced-calorie eating plan
• Documented physical activity
• Behavioral or lifestyle counseling
• Continued participation while taking medication

A general statement such as “the patient has tried diet and exercise” may not satisfy a policy requiring dates, program details, or documented clinical follow-up. Requirements differ by plan and patient population.

7. Step Therapy Was Not Completed

A plan may require the patient to try one or more preferred treatments before covering Wegovy. This is known as step therapy.

The required alternative might be:

• Another weight-management medication
• A preferred GLP-1 medication
• A lower-cost formulary option
• A structured lifestyle program
• A treatment selected according to the patient's diagnosis

A previous medication trial should be documented with:

• Medication name
• Dose
• Approximate treatment dates
• Treatment outcome
• Side effects
• Reason it was stopped

The prescriber may also document why a required medication would be unsafe or inappropriate when a legitimate contraindication or intolerance exists.

8. The Requested Dose or Quantity Did Not Meet the Plan's Rules

Wegovy treatment may involve a starting dose followed by gradual dose escalation. A request can encounter problems when:

• The prescribed dose does not match the expected treatment stage
• More medication was requested than the plan allows
• A maintenance dose was requested without documentation of titration
• The pharmacy submitted the wrong strength
• The requested formulation was not covered
• The refill was requested too early

The FDA-approved Wegovy labeling contains different administration and dosing instructions for injections and tablets. The requested form, dose, directions, and quantity should therefore match the prescription and the relevant treatment stage.¹

9. Another Semaglutide or GLP-1 Medication Appeared in Your Records

Wegovy labeling does not recommend using it together with another semaglutide-containing product or another GLP-1 receptor agonist.¹

A claim or prior authorization may be questioned if the patient's medication history still shows:

• Ozempic
• Rybelsus
• Another Wegovy formulation
• Mounjaro
• Zepbound
• Another GLP-1 or related medication

Sometimes the older medication has already been discontinued but remains active in the electronic medical record. The prescriber may need to clarify the treatment plan.

10. A Continuation Request Did Not Show Adequate Response

Initial approval does not always guarantee continued approval.

For reauthorization, some plans require evidence such as:

• A specific percentage of weight loss
• Maintenance of previous weight loss
• A reduction in BMI
• Continued lifestyle modification
• Adherence to treatment
• A positive clinical response
• Tolerability at a maintenance dose

Some current payer policies use a loss of at least 5% of baseline body weight as part of their continuation criteria, while other policies use different measurements or indication-specific requirements. Your prescriber should document both the baseline and current measurements, including the dates they were obtained.

11. The Request Was Submitted Under the Wrong Indication

Wegovy now has more than one FDA-approved use, and insurance criteria may differ according to the reason it was prescribed.

A plan may have separate criteria for:

• Chronic weight management
• Cardiovascular risk reduction
• MASH treatment
• Pediatric obesity

A patient whose weight-management benefit is excluded may still have a different coverage pathway when Wegovy is prescribed for another qualifying FDA-approved indication. This does not mean the prescriber should change the diagnosis simply to obtain coverage. The submitted diagnosis must accurately reflect the patient's medical condition and treatment purpose.

What Should You Do After a Wegovy Denial?

Step 1: Obtain the exact denial reason

Do not rely only on a message saying “not covered.” Ask for:

• The written denial notice
• The denial reason
• The denial or case reference number
• The plan's written coverage criteria
• The appeal or resubmission instructions
• The applicable deadline

Step 2: Determine whether it is an exclusion or a criteria denial

Ask: “Is Wegovy excluded from my benefit, or was the request denied because specific prior authorization criteria were not met?” The next step depends heavily on the answer.

Step 3: Check for missing or incorrect information

Verify your name and date of birth, insurance identification information, prescriber information, diagnosis, height/weight/BMI, requested dose and formulation, previous treatments, and relevant medical conditions.

Step 4: Contact the prescriber's office

Give the office the exact denial reason rather than only saying that insurance rejected the medication. Ask whether the office plans to correct and resubmit the request, add missing documentation, request an exception, submit an appeal, or discuss an alternative medication.

Step 5: Follow the plan's appeal process

Patients generally have the right to appeal many prior authorization denials. Before appealing, confirm that the plan received complete and accurate information — missing information may sometimes be corrected more quickly through resubmission. Medicare prescription-drug plans also have formal coverage-determination and appeal processes, though the exact steps depend on the program and type of request.³

Step 6: Discuss alternatives with your prescriber

When coverage cannot be obtained, ask about formulary alternatives, other FDA-approved weight-management medications, employer benefit options, manufacturer programs, structured weight-management services, or whether another covered treatment is clinically appropriate.

Never start, stop, or substitute medication solely because of information found online.

A Simple Call Script for Your Insurance Plan

You can say:

“I am calling about a prior authorization denial for Wegovy. Please tell me the exact denial reason and whether Wegovy is excluded from my benefit or can be covered if specific clinical criteria are met. I would also like a copy of the written criteria, the case reference number, and instructions for correcting, resubmitting, or appealing the request.”

Write down the date, time, representative's name, and what you were told.

Frequently Asked Questions